Tag: Tocilizumab
Tocilizumab reduces deaths in patients hospitalised with COVID-19
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) has demonstrated that an anti-inflammatory treatment, tocilizumab, reduces the risk of death when given to hospitalised patients with severe COVID-19. More...
Tocilizumab and Sarilumab reduced the relative risk of death from Covid-19 by 24%
NHS patients to receive life-saving COVID-19 treatments that could cut hospital time by 10 days. More...